Literature DB >> 12132289

[Brugada syndrome or ARVD (arrhythmogenic right ventricular dysplasia) or both? Significance and value of right precordial ECG changes].

Th Schmidt1, U Gerckens, D Ortmeyer, A Bootsveld, E Lampe, E Grube.   

Abstract

We report about a 20-year old patient suffering cardiopulmonary resuscitation due to ventricular fibrillation. We diagnosed Brugada syndrome after exclusion structural heart disease and a positive Ajmalin test and implanted an ICD. In that there is a 20-30% familiar disposition, it was necessary that all family members undergo a cardiac examination. It was found that one brother and one sister presented the beginning of a right ventricular dilatation and a fibrolipomatous area in the anterior wall segment of the right ventricle. This result is compatible with a "concealed" arrhythmogenic right ventricular dysplasia (ARVD). As a prognostic indication we decided to implant an ICD prophylactically. The case report demonstrates the value of familiar examination of patients with an unclear ventricular arrhythmogenic event.

Entities:  

Mesh:

Year:  2002        PMID: 12132289     DOI: 10.1007/s00392-002-0804-4

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  3 in total

Review 1.  The Brugada syndrome. Its relevance to paediatric practice.

Authors:  N Sreeram; T Simmers; K Brockmeier
Journal:  Z Kardiol       Date:  2004-10

2.  Epsilon-like electrocardiographic pattern in a patient with Brugada syndrome.

Authors:  Ozcan Ozeke; Umut Y Cavus; Ilyas Atar; Bulent Ozin; Erdogan Ilkay
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-07       Impact factor: 1.468

3.  Electrocardiographic features of disease progression in arrhythmogenic right ventricular cardiomyopathy/dysplasia.

Authors:  Ardan M Saguner; Sabrina Ganahl; Andrea Kraus; Samuel H Baldinger; Deniz Akdis; Arhan R Saguner; Thomas Wolber; Laurent M Haegeli; Jan Steffel; Nazmi Krasniqi; Thomas F Lüscher; Felix C Tanner; Corinna Brunckhorst; Firat Duru
Journal:  BMC Cardiovasc Disord       Date:  2015-01-19       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.